Earn 100 points for writing a review for this productBRCA testing for breast cancer
Almost 12% of women in the general population develop breast cancer during their lifetime. In India, almost 1 in 28 women are diagnosed with breast cancer
70 to 85% of Hereditary Breast and Ovarian Cancer cases are caused by mutations in either the BRCA1 or BRCA2 gene
BRCA genes are popularly known as breast cancer, early onset genes. They are “tumor suppressors'' in nature. BRCA genes repair damages or double stranded breaks in DNA and restore genomic integrity of human cells. Hence they play a vital role in maintaining normal cell growth in the body .
Harmful mutations or changes in the two genes have been associated with increased risk of cancers. Most common types of cancers with BRCA in women include breast and ovarian. Defective BRCA genes account for nearly 5-10% of breast cancer cases, while the rest are sporadic in nature.
BRCA testing for breast cancer
Almost 12% of women in the general population develop breast cancer during their lifetime. In India, almost 1 in 28 women are diagnosed with breast cancer
70 to 85% of Hereditary Breast and Ovarian Cancer cases are caused by mutations in either the BRCA1 or BRCA2 gene
BRCA genes are popularly known as breast cancer, early onset genes. They are “tumor suppressors'' in nature. BRCA genes repair damages or double stranded breaks in DNA and restore genomic integrity of human cells. Hence they play a vital role in maintaining normal cell growth in the body .
Harmful mutations or changes in the two genes have been associated with increased risk of cancers. Most common types of cancers with BRCA in women include breast and ovarian. Defective BRCA genes account for nearly 5-10% of breast cancer cases, while the rest are sporadic in nature.
Who should be tested ?
- Strong family history of breast, ovarian, fallopian tube, peritoneal, prostate, or pancreatic cancer (BRCA1&2 mutations are inherited, family members with either BRCA1 or BRCA2 mutations usually share the same mutation.)
- Personal history of Breast/ovarian cancers and meets the criteria related to : age of diagnosis, type of cancer/Bilateral Cancers ancestry.
- Personal/family history of ovarian, fallopian tube, or primary peritoneal cancer.
- History of breast cancer in Males.
- A relative with a known deleterious mutation in BRCA1 or BRCA2 genes.
- Ashkenazi Jewish or Eastern European ancestry.
Test sample requirements
FFPE (Formalin-Fixed Paraffin-Embedded) Sample - Somatic cases
Blood Sample - Germline cases
How it Works?
Sample Collection
Your Doctor places a request for the test. The sample is tested for the susceptibility.
Lab Processing
The sample processed using NGS Technique
Data Analysis
Your genetic sequence is subjected to extensive analysis and a report is generated based on the genetic findings
Genetic Counseling
Our genetic counselor will discuss your results at a time and day convenient for you.
